India’s Dr. Reddy’s Laboratories Ltd. Makes 450 Million Euros Bid For Germany’s Betapharm Arzneimittel GmbH

BOMBAY (AFX) - Dr. Reddy's Laboratories has offered 450 mln eur for acquiring German generic drugs major Betapharm Arzneimittel GmbH, Business Standard reported. The deal, if it goes through, will be the biggest overseas acquisition by an Indian pharmaceuticals company, the newspaper noted.
MORE ON THIS TOPIC